Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

“Cardiol Therapeutics (NASDAQ: CRDL) Myocarditis Breakthrough Featured on Fox Business: CardiolRx™ Poised for Medical Impact more stocks inside…”

"Cardiol Therapeutics (<a href="https://markets.financialcontent.com/pennwell.industriallaser/quote?Symbol=NQ%3ACRDL">NASDAQ: CRDL</a>) Myocarditis Breakthrough Featured on Fox Business: CardiolRx™ Poised for Medical Impact more stocks inside..."

Cardiol Therapeutics (NASDAQ: CRDL) recently showcased its groundbreaking Myocarditis treatment, CardiolRx™, on Fox Business's Making Money with Charles Payne, highlighting the potential life-saving impact of this innovative therapy.

In a dynamic show of market strength, Cardiol Therapeutics Inc. (NASDAQ: CRDL) has completed its pivotal Phase II MAvERIC-Pilot study, showcasing significant reductions in pain and inflammation for recurrent pericarditis patients after just 8 weeks of treatment with its breakthrough CBD-based therapy, CardiolRx™. With full results set to be presented at the prestigious American Heart Association (AHA) Scientific Sessions on November 18, 2024, this study, led by Dr. S. Allen Luis, paves the way for Phase III trials and positions CardiolRx™ as a promising non-immunosuppressive treatment targeting inflammation and fibrosis. The potential to drastically improve the quality of life for heart disease patients makes this development a major milestone in cardiovascular care.

Meanwhile, Peraso Inc. (NASDAQ: PRSO), a recognized leader in mmWave technology, continues to impress investors with a 133% year-over-year revenue increase in Q2 2024, bringing total revenue to $4.2 million and surpassing expectations. Ladenburg Thalmann issued a buy rating with a $3.75 target, spotlighting the company’s robust performance, driven by a 180% surge in mmWave sales and strong gains in the memory segment. With projections to hit $16 million in revenue by 2025, Peraso is well-positioned for future growth, fueling massive investor interest.

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL), exclusive U.S. distributor of BIDI® Stick and global distributor of VEEBA® through Philip Morris Products SA, is rapidly expanding. After securing $6 million in June 2024 for its expansion initiatives, Kaival Brands saw its stock soar by 22.13%, closing at $0.75 on heavy trading volume. Despite market volatility, the company's low float and strong fundamentals continue to signal substantial investor upside, with after-hours trading showing continued momentum.

Stocks Gaining Pre-Market Attention:

1.     Smart for Life, Inc. (NASDAQ: SMFL): HRT Financial LP has acquired a new stake in Smart for Life, signaling growing investor interest in the health and wellness sector.

2.     Pineapple Energy Inc. (NASDAQ: PEGY): After a recent stock decline, Pineapple Energy has entered into exchange agreements to swap Series A preferred stock and warrants for Series C preferred stock, convertible at $0.45 per share. A potential reversal to the uptrend is anticipated, sparking renewed interest.

3.     Tenon Medical, Inc. (NASDAQ: TNON): Following a 1:8 reverse stock split, Tenon Medical has achieved market acceptance with a low float and strong fundamentals, pointing to considerable upside potential.

4.     Unusual Machines, Inc. (NYSE American: UMAC) has received orders for over 6,700 Rotor Riot Brave F7 Flight Controllers, the first FPV-specific controller listed on the Blue UAS Framework, solidifying its role as a key FPV technology supplier to the U.S. Department of Defense and commercial markets.

These seven companies are leveraging cutting-edge technology and innovation across diverse sectors, showcasing impressive growth and market potential for investors in 2024 and beyond.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.